Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
22 hedge funds and large institutions have $5.54M invested in Alexza Pharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 9 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less funds holding
Funds holding: 28 → 22 (-6)
53% less capital invested
Capital invested by funds: $11.7M → $5.54M (-$6.19M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$35K |
| 2 |
Citigroup
New York
|
+$8.12K |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$7.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.43K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$829K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$131K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$109K |
| 4 |
Goldman Sachs
New York
|
-$90K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$44K |
ALXA Hedge Fund Activity: Q2 2015 in Review
22 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2015, worth a combined $5.54M — down 53% from $11.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ALXA and 3 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $35K. The largest seller was C WorldWide Group, exiting entirely with an estimated $829K sold.
- 22 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2015, down from 28 in Q1 2015.
- Funds reported $5.54M of Alexza Pharmaceuticals Inc stock for Q2 2015, down 53% quarter-over-quarter.
- 3 funds opened new Alexza Pharmaceuticals Inc positions in Q2 2015 and 9 closed out, a net change of -6 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q2 2015 was Virtu KCG Holdings, an estimated $35K added.
- The largest Alexza Pharmaceuticals Inc seller in Q2 2015 was C WorldWide Group, an estimated $829K sold.
Based on aggregated 13F filings for Q2 2015.